Otolaryngology Doctors in Overland Park, KS Accepting Medicare

13 Otolaryngology doctors found. Showing 1 - 13

Dr. Kenneth Allan Buchwach, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5701 W 119th St, Suite 320, Overland Park, KS 66209 Phone: 913-491-1400

Mark Jeffrey Maslan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 5520 College Blvd, Suite 350, Overland Park, KS 66211 Phone: 913-663-5100    Fax: 913-663-3354

Dr. Mark Stephen Walton, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 5370 College Blvd, Suite 100, Overland Park, KS 66211 Phone: 913-599-4800    Fax: 913-599-2992

Dr. Jeffrey D Markey, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 14340 Metcalf Ave, Overland Park, KS 66223 Phone: 816-478-4200

Eugene Bortnick, MD Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5520 College Blvd, Suite 350, Overland Park, KS 66211 Phone: 913-663-5100    Fax: 913-663-3354

Dr. Carson Tyler Williams, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5370 College Blvd Ste 100, Overland Park, KS 66211 Phone: 913-599-4800    Fax: 913-599-2297

Dr. Christopher T. Rose, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 11400 W 135th St, Overland Park, KS 66221 Phone: 913-814-8800

David Todd Rudman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5701 W 119th St Ste 425, Overland Park, KS 66209 Phone: 913-663-5100

Dr. Robert F Thompson, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 5370 College Blvd, Suite 100, Overland Park, KS 66211 Phone: 913-599-4800    Fax: 913-599-2992

Mitchell Challis, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5370 College Blvd, Overland Park, KS 66211 Phone: 913-599-4800    Fax: 913-599-2992

Dr. Lynn H Roh, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10787 Nall Ave Ste 220, Overland Park, KS 66211 Phone: 913-574-0780

Dr. Steven Frank Ellis, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 5370 College Blvd, Suite 100, Overland Park, KS 66211 Phone: 913-599-4800    Fax: 913-599-2992

Dr. Thomas P Eyen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 5701 W 119th St Bldg D, Overland Park, KS 66209 Phone: 816-478-4200

News Archive

Exercise programme for migraine sufferers

Many patients who suffer from migraines avoid taking aerobic exercise because they are afraid that the physical activity may bring on a serious migraine attack.

Reconciliation update: Some Dems, GOP and industry groups wary health bill strategy

The Los Angeles Times: "Obama's signature ability to inspire fellow Democrats and Pelosi's well-honed ability to read their parochial needs will be tested as they tackle the job of finding the last stubborn votes for the healthcare bill. ... "Under the Democrats' strategy, the House would pass the Senate's version of the bill. Then both chambers would approve changes under the budget reconciliation process, which could pass the Senate with a simple 51-vote majority. Democrats hope to finish by the end of the month" (Hook and Levey, 3/8).

Walking prevents bone loss caused from prostate cancer treatment

Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men, according to a study presented on October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

Proteon's PRT-201 gets orphan drug designation for prevention of arteriovenous access dysfunction

Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced that its lead product, PRT-201, has received orphan drug designation in the European Union for the prevention of arteriovenous access dysfunction in hemodialysis patients.

DaVita releases second annual corporate social responsibility report

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today released its second annual corporate social responsibility (CSR) report, which highlights the company's philanthropic, sustainability and community-building efforts through 2009.

Read more Medical News

› Verified 1 days ago